6-K: U.S. FDA Approves Subcutaneous Administration of Takeda’s ENTYVIO® (vedolizumab) for Maintenance Therapy in Moderately to Severely Active Crohn’s Disease
Apr 19 06:15 ET
TAKEDA PHARMACEUTICAL CO LTD | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Apr 15 06:33 ET
TAKEDA PHARMACEUTICAL CO LTD | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Takeda Pharmaceutical Company Limited(4.8%)
Apr 10 06:12 ET
TAKEDA PHARMACEUTICAL CO LTD | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Takeda Pharmaceutical Company Limited(5.4%)
Apr 1 06:21 ET
TAKEDA PHARMACEUTICAL CO LTD | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Mar 27 06:38 ET
TAKEDA PHARMACEUTICAL CO LTD | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Feb 9 06:09 ET
TAKEDA PHARMACEUTICAL CO LTD | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BlackRock, Inc.(7.7%)
Feb 6 09:43 ET
TAKEDA PHARMACEUTICAL CO LTD | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Sumitomo Mitsui Trust Holdings, Inc.(5.5%)
Feb 5 06:27 ET
TAKEDA PHARMACEUTICAL CO LTD | 6-K: Report of foreign private issuer (related to financial reporting)
Feb 2 06:20 ET
TAKEDA PHARMACEUTICAL CO LTD | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Feb 1 06:21 ET
TAKEDA PHARMACEUTICAL CO LTD | 6-K: Report of foreign private issuer (related to financial reporting)
Feb 1 06:12 ET
TAKEDA PHARMACEUTICAL CO LTD | 4: Statement of changes in beneficial ownership of securities-10% Owner TAKEDA PHARMACEUTICAL CO LTD
Jan 25 06:14 ET
TAKEDA PHARMACEUTICAL CO LTD | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Takeda Pharmaceutical Company Limited(6.6%)
Jan 25 06:14 ET
TAKEDA PHARMACEUTICAL CO LTD | SC 13G: Statement of acquisition of beneficial ownership by individuals-Takeda Pharmaceutical Company Limited(5.2%),Takeda Ventures, Inc(5.2%)
Jan 19 00:00 ET
TAKEDA PHARMACEUTICAL CO LTD | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Jan 16 00:00 ET
TAKEDA PHARMACEUTICAL CO LTD | 6-K: Report of foreign private issuer (related to financial reporting)
Dec 14, 2023 06:01 ET
TAKEDA PHARMACEUTICAL CO LTD | 6-K: Report of foreign private issuer (related to financial reporting)
Nov 30, 2023 06:01 ET
TAKEDA PHARMACEUTICAL CO LTD | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Nov 13, 2023 06:05 ET
TAKEDA PHARMACEUTICAL CO LTD | 6-K: Report of foreign private issuer (related to financial reporting)
Oct 30, 2023 06:02 ET
TAKEDA PHARMACEUTICAL CO LTD | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Oct 26, 2023 06:22 ET
No Data
No Data